Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

Up to 85 percent of prostate cancers are diagnosed in the early stages, when they are still curable.Even when diagnosed at an advanced stage, most prostate cancers respond well to treatment. The first ...